K. Coote

452 total citations
11 papers, 309 citations indexed

About

K. Coote is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, K. Coote has authored 11 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in K. Coote's work include Cystic Fibrosis Research Advances (6 papers), Ion Transport and Channel Regulation (4 papers) and Asthma and respiratory diseases (4 papers). K. Coote is often cited by papers focused on Cystic Fibrosis Research Advances (6 papers), Ion Transport and Channel Regulation (4 papers) and Asthma and respiratory diseases (4 papers). K. Coote collaborates with scholars based in United Kingdom, Switzerland and United States. K. Coote's co-authors include Henry Danahay, Rosemary Sugar, Hazel C. Atherton, Zarin Brown, Neil J. Press, Ruth Webster, Christopher S. Stevenson, Keith Butler, Alan Jackson and June Giddings and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

K. Coote

11 papers receiving 293 citations

Peers

K. Coote
Emily Falk Libby United States
Wynn Burke United States
K. Kohri Japan
Evan A. Elko United States
Roy H. E. Cloots Netherlands
Jeffrey Wu United States
K. Coote
Citations per year, relative to K. Coote K. Coote (= 1×) peers Elizabeth Matthes

Countries citing papers authored by K. Coote

Since Specialization
Citations

This map shows the geographic impact of K. Coote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Coote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Coote more than expected).

Fields of papers citing papers by K. Coote

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Coote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Coote. The network helps show where K. Coote may publish in the future.

Co-authorship network of co-authors of K. Coote

This figure shows the co-authorship network connecting the top 25 collaborators of K. Coote. A scholar is included among the top collaborators of K. Coote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Coote. K. Coote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Porter, Joseph J., Sacha Spelier, K. Coote, et al.. (2025). ACE-tRNAs are a platform technology for suppressing nonsense mutations that cause cystic fibrosis. Nucleic Acids Research. 53(13). 5 indexed citations
2.
Ellis, Ethan, et al.. (2025). A streamlined base editor engineering strategy to reduce bystander editing. Nature Communications. 16(1). 8115–8115. 1 indexed citations
3.
Excoffon, Katherine J. D. A., Mia J. Smith, Shih-Yao Lin, et al.. (2021). 584: Delivery of SP-101 restores CFTR function in human CF airway epithelial cultures and drives hCFTRΔR transgene expression in the airways of ferrets. Journal of Cystic Fibrosis. 20. S278–S278. 1 indexed citations
4.
Jiang, Tingting, Jordana M. Henderson, K. Coote, et al.. (2020). Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope. Nature Communications. 11(1). 1979–1979. 82 indexed citations
5.
Hunt, Thomas A., Stephen P. Collingwood, K. Coote, et al.. (2012). Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 2: α-Branched quaternary amines. Bioorganic & Medicinal Chemistry Letters. 22(8). 2877–2879. 14 indexed citations
6.
Hunt, Thomas A., Stephen P. Collingwood, K. Coote, et al.. (2011). Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: Quaternary amines. Bioorganic & Medicinal Chemistry Letters. 22(2). 929–932. 23 indexed citations
7.
Schmidt, Philipp, Catherine Cannet, Rainer Kneuer, et al.. (2009). In vivo assessments of mucus dynamics in the rat lung using a Gd‐Cy5.5‐bilabeled contrast agent for magnetic resonance and optical imaging. Magnetic Resonance in Medicine. 62(5). 1164–1174. 5 indexed citations
8.
Coote, K., Rosemary Sugar, Allan H. Young, et al.. (2009). Camostat Attenuates Airway Epithelial Sodium Channel Function in Vivo through the Inhibition of a Channel-Activating Protease. Journal of Pharmacology and Experimental Therapeutics. 329(2). 764–774. 76 indexed citations
9.
Coote, K., Hazel C. Atherton, Allan H. Young, et al.. (2008). The guinea‐pig tracheal potential difference as an in vivo model for the study of epithelial sodium channel function in the airways. British Journal of Pharmacology. 155(7). 1025–1033. 10 indexed citations
10.
Stevenson, Christopher S., K. Coote, Ruth Webster, et al.. (2004). Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect. American Journal of Physiology-Lung Cellular and Molecular Physiology. 288(3). L514–L522. 78 indexed citations
11.
Coote, K., Andy Nicholls, Hazel C. Atherton, Rosemary Sugar, & Henry Danahay. (2004). MUCOCILIARY CLEARANCE IS ENHANCED IN RAT MODELS OF CIGARETTE SMOKE AND LIPOPOLYSACCHARIDE-INDUCED LUNG DISEASE. Experimental Lung Research. 30(1). 59–71. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026